Business Description
Shin Nippon Biomedical Laboratories Ltd
ISIN : JP3379950003
Description
Shin Nippon Biomedical Laboratories Ltd provides pre-clinical testing services in the pharmaceutical industry in Japan. The company provides a range of services such as pre-clinical and analysis studies, contracted clinical trials, SMO, CRO, translational research and cancer treatment.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.32 | |||||
| Equity-to-Asset | 0.41 | |||||
| Debt-to-Equity | 0.96 | |||||
| Debt-to-EBITDA | 6.4 | |||||
| Interest Coverage | 19.59 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 1.38 | |||||
| Beneish M-Score | -2.15 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 20.5 | |||||
| 3-Year EBITDA Growth Rate | 17.4 | |||||
| 3-Year EPS without NRI Growth Rate | 20.3 | |||||
| 3-Year Book Growth Rate | 29.4 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 8.28 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 74.24 | |||||
| 9-Day RSI | 71.88 | |||||
| 14-Day RSI | 68.74 | |||||
| 6-1 Month Momentum % | -11.84 | |||||
| 12-1 Month Momentum % | -26.74 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.18 | |||||
| Quick Ratio | 0.69 | |||||
| Cash Ratio | 0.39 | |||||
| Days Inventory | 366.51 | |||||
| Days Sales Outstanding | 79.94 | |||||
| Days Payable | 16.33 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.51 | |||||
| Dividend Payout Ratio | 0.28 | |||||
| 3-Year Dividend Growth Rate | 115.4 | |||||
| Forward Dividend Yield % | 3.51 | |||||
| 5-Year Yield-on-Cost % | 87.79 | |||||
| Shareholder Yield % | -12.06 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 53.88 | |||||
| Operating Margin % | 10.65 | |||||
| Net Margin % | 16.34 | |||||
| FCF Margin % | -24.81 | |||||
| ROE % | 12.93 | |||||
| ROA % | 5.61 | |||||
| ROIC % | 3.32 | |||||
| 3-Year ROIIC % | 3.17 | |||||
| ROC (Joel Greenblatt) % | 18.15 | |||||
| ROCE % | 10.54 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 13.85 | |||||
| Forward PE Ratio | 20.67 | |||||
| PE Ratio without NRI | 13.5 | |||||
| PEG Ratio | 0.55 | |||||
| PS Ratio | 2.26 | |||||
| PB Ratio | 1.63 | |||||
| Price-to-Tangible-Book | 1.73 | |||||
| Price-to-Operating-Cash-Flow | 28.14 | |||||
| EV-to-EBIT | 15.17 | |||||
| EV-to-EBITDA | 15.17 | |||||
| EV-to-Revenue | 3.18 | |||||
| EV-to-FCF | -12.8 | |||||
| Price-to-Median-PS-Value | 1.56 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.16 | |||||
| Price-to-Graham-Number | 1.28 | |||||
| Earnings Yield (Greenblatt) % | 6.59 | |||||
| FCF Yield % | -10.96 | |||||
| Forward Rate of Return (Yacktman) % | 21.15 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shin Nippon Biomedical Laboratories Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 26,195.018 | ||
| EPS (TTM) (円) | 102.804 | ||
| Beta | -0.21 | ||
| Volatility % | 20.53 | ||
| 14-Day RSI | 68.74 | ||
| 14-Day ATR (円) | 46.761639 | ||
| 20-Day SMA (円) | 1268.4 | ||
| 12-1 Month Momentum % | -26.74 | ||
| 52-Week Range (円) | 970 - 1996 | ||
| Shares Outstanding (Mil) | 41.63 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shin Nippon Biomedical Laboratories Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shin Nippon Biomedical Laboratories Ltd Stock Events
| Event | Date | Price(円) | ||
|---|---|---|---|---|
| No Event Data | ||||
Shin Nippon Biomedical Laboratories Ltd Frequently Asked Questions
What is Shin Nippon Biomedical Laboratories Ltd(TSE:2395)'s stock price today?
The current price of TSE:2395 is 円1424.00. The 52 week high of TSE:2395 is 円1996.00 and 52 week low is 円970.00.
When is next earnings date of Shin Nippon Biomedical Laboratories Ltd(TSE:2395)?
The next earnings date of Shin Nippon Biomedical Laboratories Ltd(TSE:2395) is .
Does Shin Nippon Biomedical Laboratories Ltd(TSE:2395) pay dividends? If so, how much?
The Dividend Yield %  of Shin Nippon Biomedical Laboratories Ltd(TSE:2395) is 3.51% (As of Today), Highest Dividend Payout Ratio of Shin Nippon Biomedical Laboratories Ltd(TSE:2395) was 0.37. The lowest was 0.06. And the median was 0.14. The  Forward Dividend Yield % of Shin Nippon Biomedical Laboratories Ltd(TSE:2395) is 3.51%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers